Clinical trial
REcurrent VEnous Thromboembolism Risk Stratification Evaluation A Study to Develop a Clinical Prediction Rule to Predict Low Recurrence Risk in Patients With Idiopathic Venous Thromboembolism.
NCT00261014 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REcurrent VEnous Thromboembolism Risk Stratification Evaluation A Study to Develop a Clinical Prediction Rule to Predict Low Recurrence Risk in Patients With Idiopathic Venous Thromboembolism.
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2002
- Completion date
- March 31, 2016
- Enrollment
- 800 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis